SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-17-002937
Filing Date
2017-04-26
Accepted
2017-04-26 16:06:24
Documents
4
Period of Report
2017-06-07
Effectiveness Date
2017-04-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2231901zdef14a.htm DEF 14A 340000
2 G102608.JPG g102608.jpg GRAPHIC 5386
3 G24472BGI001.GIF g24472bgi001.gif GRAPHIC 129939
4 G24472BGI002.GIF g24472bgi002.gif GRAPHIC 114368
  Complete submission text file 0001047469-17-002937.txt   685237
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37467 | Film No.: 17784382
SIC: 2834 Pharmaceutical Preparations